Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.960
-0.100 (-3.27%)
At close: Jun 8, 2026, 4:00 PM EDT
2.950
-0.010 (-0.34%)
After-hours: Jun 8, 2026, 4:40 PM EDT

Prime Medicine Revenue

Prime Medicine had revenue of $856.00K in the quarter ending March 31, 2026, a decrease of -41.13%. This brings the company's revenue in the last twelve months to $4.03M, up 4.89% year-over-year. In the year 2025, Prime Medicine had annual revenue of $4.63M with 55.28% growth.

Revenue (ttm)
$4.03M
Revenue Growth
+4.89%
P/S Ratio
132.53
Revenue / Employee
$27,630
Employees
146
Market Cap
534.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.63M1.65M55.28%
Dec 31, 20242.98M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MiMedx Group389.42M
Rigel Pharmaceuticals299.77M
Ginkgo Bioworks Holdings151.40M
Gyre Therapeutics117.05M
XOMA Royalty48.56M
ProKidney889.00K
Altimmune36.00K
Revenue Rankings